Immunogenicity of infliximab and adalimumab.

Immunogenicity of infliximab and adalimumab. Expert Opin Drug Saf. 2019 Apr 02;: Authors: Murdaca G, Negrini S, Greco M, Schiavi C, Giusti F, Borro M, Puppo F PMID: 30938213 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/30938213?dopt=Abstract

Source: Expert Opinion on Drug Safety - April 3, 2019 Category: Drugs & Pharmacology Tags: Expert Opin Drug Saf Source Type: research

More News: Drugs & Pharmacology | Humira | Remicade